A

Advanced Respiratory and Sleep Medicine, PLLC | Huntersville, NC

Research site

Location

16507 Northcross Drive, suite F, Huntersville, North Carolina, United States of America

Site insights

Top conditions

Top treatments

FT218

Mazindol

AD109

SAR440340

Aroxybutynin

XYWAV

BI 1291583

Verekitug

Astegolimab

High-Sodium Oxybate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Felix Kurniawan

Verified by this site

Active trials

4 of 20 total trials

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

A Randomized, Double-blind, Placebo-controlled, Multiple Dose-Ranging Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic...

Active, not recruiting

COPD

Other: Placebo

Biological: Biological: Solrikitug high dose

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (ATLAS)

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Active, not recruiting

Asthma

Drug: Placebo

Drug: Dupilumab

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

This study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and...

Enrolling

Bronchiectasis

Drug: Placebo matching BI 1291583

Drug: BI 1291583